REACT-Siemens [COVID-19]
Research type
Research Study
Full title
Self-testing for the assessment of capillary blood collection and saliva for anti-SARS-CoV-2 antibody detection
IRAS ID
292932
Contact name
Paul Elliott
Contact email
Sponsor organisation
Imperial College London
Duration of Study in the UK
0 years, 6 months, 30 days
Research summary
This is a research study involving tests for antibodies of the virus which causes COVID-19.
The study will evaluate alternative means of sampling people for the presence of COVID 19 antibodies e.g. use of saliva samples and finger prick blood and will directly compare these approaches with conventional tests such as blood sampling from the vein.REC name
South Central - Berkshire B Research Ethics Committee
REC reference
20/SC/0449
Date of REC Opinion
16 Dec 2020
REC opinion
Further Information Favourable Opinion